186 related articles for article (PubMed ID: 15994295)
1. Renal carcinoma-associated transcription factors TFE3 and TFEB are leukemia inhibitory factor-responsive transcription activators of E-cadherin.
Huan C; Sashital D; Hailemariam T; Kelly ML; Roman CA
J Biol Chem; 2005 Aug; 280(34):30225-35. PubMed ID: 15994295
[TBL] [Abstract][Full Text] [Related]
2. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation.
Davis IJ; Hsi BL; Arroyo JD; Vargas SO; Yeh YA; Motyckova G; Valencia P; Perez-Atayde AR; Argani P; Ladanyi M; Fletcher JA; Fisher DE
Proc Natl Acad Sci U S A; 2003 May; 100(10):6051-6. PubMed ID: 12719541
[TBL] [Abstract][Full Text] [Related]
3. TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes.
Verastegui C; Bertolotto C; Bille K; Abbe P; Ortonne JP; Ballotti R
Mol Endocrinol; 2000 Mar; 14(3):449-56. PubMed ID: 10707962
[TBL] [Abstract][Full Text] [Related]
4. The FACT complex facilitates expression of lysosomal and antioxidant genes through binding to TFEB and TFE3.
Jeong E; Martina JA; Contreras PS; Lee J; Puertollano R
Autophagy; 2022 Oct; 18(10):2333-2349. PubMed ID: 35230915
[TBL] [Abstract][Full Text] [Related]
5. Re-evaluation of histological type by immunohistochemical and genetic study of transcription factors (TFE3 and TFEB) of VHL gene mutation-negative clear cell renal cell carcinoma and other special types of renal tumor.
Kuroda N; Kawada C; Tamura K; Hiroi M; Hes O; Michal M; Wada Y; Inoue K; Ohara M; Mizuno K; Shuin T; Lee GH
Med Mol Morphol; 2011 Mar; 44(1):46-51. PubMed ID: 21424937
[TBL] [Abstract][Full Text] [Related]
6. ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation.
Brown C; Gaspar J; Pettit A; Lee R; Gu X; Wang H; Manning C; Voland C; Goldring SR; Goldring MB; Libermann TA; Gravallese EM; Oettgen P
J Biol Chem; 2004 Mar; 279(13):12794-803. PubMed ID: 14715662
[TBL] [Abstract][Full Text] [Related]
7. MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated epithelial-mesenchymal transdifferentiation.
Hong CF; Chou YT; Lin YS; Wu CW
J Biol Chem; 2009 Jul; 284(29):19613-22. PubMed ID: 19443654
[TBL] [Abstract][Full Text] [Related]
8. CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, AND CBF1.
Mann J; Oakley F; Johnson PW; Mann DA
J Biol Chem; 2002 May; 277(19):17125-38. PubMed ID: 11886848
[TBL] [Abstract][Full Text] [Related]
9. TFEC, a basic helix-loop-helix protein, forms heterodimers with TFE3 and inhibits TFE3-dependent transcription activation.
Zhao GQ; Zhao Q; Zhou X; Mattei MG; de Crombrugghe B
Mol Cell Biol; 1993 Aug; 13(8):4505-12. PubMed ID: 8336698
[TBL] [Abstract][Full Text] [Related]
10. The basic helix-loop-helix-zipper domain of TFE3 mediates enhancer-promoter interaction.
Artandi SE; Cooper C; Shrivastava A; Calame K
Mol Cell Biol; 1994 Dec; 14(12):7704-16. PubMed ID: 7969114
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution.
Kuiper RP; Schepens M; Thijssen J; van Asseldonk M; van den Berg E; Bridge J; Schuuring E; Schoenmakers EF; van Kessel AG
Hum Mol Genet; 2003 Jul; 12(14):1661-9. PubMed ID: 12837690
[TBL] [Abstract][Full Text] [Related]
12. Aberrant regulation of survivin by the RB/E2F family of proteins.
Jiang Y; Saavedra HI; Holloway MP; Leone G; Altura RA
J Biol Chem; 2004 Sep; 279(39):40511-20. PubMed ID: 15271987
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopatholigic features of renal cell carcinoma associated with chromosome X inversion harboring gene fusions involving TFE3].
Zhao YN; Wang XT; Xia QY; Wang GP; Sun SY; Zhao LF; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):574-579. PubMed ID: 30107660
[No Abstract] [Full Text] [Related]
14. Transcription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunity.
Huan C; Kelly ML; Steele R; Shapira I; Gottesman SR; Roman CA
Nat Immunol; 2006 Oct; 7(10):1082-91. PubMed ID: 16936731
[TBL] [Abstract][Full Text] [Related]
15. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
Werner H; Roberts CT; Rauscher FJ; LeRoith D
J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
[TBL] [Abstract][Full Text] [Related]
16. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene.
Hua X; Liu X; Ansari DO; Lodish HF
Genes Dev; 1998 Oct; 12(19):3084-95. PubMed ID: 9765209
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma.
Damayanti NP; Budka JA; Khella HWZ; Ferris MW; Ku SY; Kauffman E; Wood AC; Ahmed K; Chintala VN; Adelaiye-Ogala R; Elbanna M; Orillion A; Chintala S; Kao C; Linehan WM; Yousef GM; Hollenhorst PC; Pili R
Clin Cancer Res; 2018 Dec; 24(23):5977-5989. PubMed ID: 30061365
[TBL] [Abstract][Full Text] [Related]
18. The transcriptional repressor Nkx6.1 also functions as a deoxyribonucleic acid context-dependent transcriptional activator during pancreatic beta-cell differentiation: evidence for feedback activation of the nkx6.1 gene by Nkx6.1.
Iype T; Taylor DG; Ziesmann SM; Garmey JC; Watada H; Mirmira RG
Mol Endocrinol; 2004 Jun; 18(6):1363-75. PubMed ID: 15056733
[TBL] [Abstract][Full Text] [Related]
19. Both Max and TFE3 cooperate with Smad proteins to bind the plasminogen activator inhibitor-1 promoter, but they have opposite effects on transcriptional activity.
Grinberg AV; Kerppola T
J Biol Chem; 2003 Mar; 278(13):11227-36. PubMed ID: 12551947
[TBL] [Abstract][Full Text] [Related]
20. Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells.
Begon DY; Delacroix L; Vernimmen D; Jackers P; Winkler R
J Biol Chem; 2005 Jul; 280(26):24428-34. PubMed ID: 15870067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
